Eli Lilly: further share buybacks and dividend increase

(CercleFinance.com) - Eli Lilly announced last night the launch of a new $15 billion share buyback program and a 15% dividend increase, two pieces of news that were greeted rather favorably on Tuesday by the New York Stock Exchange.


Just over 15 minutes after opening, the US pharmaceutical group's shares were up 0.9%, compared with a 0.1% gain for the S&P 500 index.

The Indianapolis, Indiana-based laboratory plans to increase its dividend for the seventh consecutive year, raising it to a quarterly amount of $1.50 per share from the first quarter of 2025.

This coupon will be paid on March 10 to shareholders registered before February 14.

The new share repurchase program replaces a previous share repurchase plan that recently expired.

In a press release, Lilly points out that it is entering a phase of strong growth, due to the generalization of anti-obesity drugs, which will push it to increase its investments.

In view of our company's solid financial profile, we will also be increasing the amount of capital returned to shareholders", stresses Lucas Montarce, Lilly's CFO, adding that these redistributions will be carried out over the next three years.

Copyright (c) 2024 CercleFinance.com. All rights reserved.